HDAC3 and diabetes mellitus: Mice with β-cell-specific HDAC3 deletion displayed decreased insulin content, disrupted glucose-stimulated insulin secretion and tolerance, and dramatically enhanced susceptibility to low dose STZ induced diabetes.